US medtech firm Terumo Blood and Cell Technologies has appointed Liza Loidolt as general manager of its cell and gene therapy ...

Pichia pastoris is emerging as a versatile, efficient alternative for protein production, bridging microbial and mammalian expression systems.

Fortress Biotech, Inc. ( FBIO) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST ...

In this exclusive interview, Panda Biotech’s President Dixie Carter outlines how U.S.-grown, cottonized hemp is moving from pilot to mainstream: a zero-water, chemical-free, zero-waste process, ...

Scholar Rock Holding Company ( SRRK) is a Boston-based, clinical-stage biotech that was founded in 2012, focusing on ...

Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...

Lokesh met Australian Consul General’s representative Jilai Saki and officials from James Cook University to explore academic ...

Shaperon Inc. (KOSDAQ: 378800) a clinical-stage biotechnology company specializing in GPCR19-targeted immunomodulatory drugs, ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and ...

MRT-8102 is a selective, potent, and durable NEK7 degrader. Activation of the NLRP3 inflammasome critically depends on NEK7. Administration of MRT-8102 led to inhibition of NLRP3 inflammasome in vitro ...

SandboxAQ, a U.S.-based artificial intelligence and quantum technology firm, signed an agreement with Bahrain's sovereign wealth fund on Monday aimed at speeding up the development of drugs and ...

Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion ...